BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16988590)

  • 1. The changing scene of adult acute lymphoblastic leukemia.
    Vitale A; Guarini A; Chiaretti S; Foà R
    Curr Opin Oncol; 2006 Nov; 18(6):652-9. PubMed ID: 16988590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress in the treatment of adults with acute lymphoblastic leukemia.
    Larson S; Stock W
    Curr Opin Hematol; 2008 Jul; 15(4):400-7. PubMed ID: 18536580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating molecular information into treatment of childhood acute lymphoblastic leukemia--a perspective from the BFM Study Group.
    Stanulla M; Cario G; Meissner B; Schrauder A; Möricke A; Riehm H; Schrappe M
    Blood Cells Mol Dis; 2007; 39(2):160-3. PubMed ID: 17532236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute lymphoblastic leukemia: diagnosis and detection of minimal residual disease following therapy.
    Digiuseppe JA
    Clin Lab Med; 2007 Sep; 27(3):533-49, vi. PubMed ID: 17658406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group.
    Bader P; Kreyenberg H; Henze GH; Eckert C; Reising M; Willasch A; Barth A; Borkhardt A; Peters C; Handgretinger R; Sykora KW; Holter W; Kabisch H; Klingebiel T; von Stackelberg A;
    J Clin Oncol; 2009 Jan; 27(3):377-84. PubMed ID: 19064980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell acute lymphoblastic leukaemia: recent molecular biology findings.
    Kraszewska MD; Dawidowska M; Szczepański T; Witt M
    Br J Haematol; 2012 Feb; 156(3):303-15. PubMed ID: 22145858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
    Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
    Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infant acute bilineal leukemia.
    Derwich K; Sedek L; Meyer C; Pieczonka A; Dawidowska M; Gaworczyk A; Wachowiak J; Konatkowska B; Witt M; Marschalek R; Szczepański T
    Leuk Res; 2009 Jul; 33(7):1005-8. PubMed ID: 19286255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of CD49f in precursor B-cell acute lymphoblastic leukemia: potential usefulness in minimal residual disease detection.
    DiGiuseppe JA; Fuller SG; Borowitz MJ
    Cytometry B Clin Cytom; 2009 Mar; 76(2):150-5. PubMed ID: 18831072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biology of acute lymphoblastic leukemia (ALL): clinical and therapeutic relevance.
    Graux C
    Transfus Apher Sci; 2011 Apr; 44(2):183-9. PubMed ID: 21354375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow minimal disseminated disease (MDD) and minimal residual disease (MRD) in childhood T-cell lymphoblastic lymphoma stage III, detected by flow cytometry (FC) and real-time quantitative polymerase chain reaction (RQ-PCR).
    Stark B; Avigad S; Luria D; Manor S; Reshef-Ronen T; Avrahami G; Yaniv I
    Pediatr Blood Cancer; 2009 Jan; 52(1):20-5. PubMed ID: 19006253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of early precursors of t(12;21) positive pediatric acute lymphoblastic leukemia during follow-up.
    László R; Alpár D; Kajtár B; Lacza A; Ottóffy G; Kiss C; Bartyik K; Nagy K; Pajor L
    Pediatr Blood Cancer; 2010 Jan; 54(1):158-60. PubMed ID: 19813247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in acute lymphoblastic leukemia in adults.
    Ribera JM
    Curr Opin Oncol; 2011 Nov; 23(6):692-9. PubMed ID: 21892082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute lymphoblastic leukemia.
    Onciu M
    Hematol Oncol Clin North Am; 2009 Aug; 23(4):655-74. PubMed ID: 19577163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of adult acute lymphoblastic leukemia.
    Gökbuget N; Hoelzer D
    Semin Hematol; 2009 Jan; 46(1):64-75. PubMed ID: 19100369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The extent of minimal residual disease reduction after the first 4-week imatinib therapy determines outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Lee S; Kim YJ; Chung NG; Lim J; Lee DG; Kim HJ; Min CK; Lee JW; Min WS; Kim CC
    Cancer; 2009 Feb; 115(3):561-70. PubMed ID: 19117346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eliminating a gold standard in childhood acute lymphoblastic leukemia?
    Raetz EA; Carroll WL
    Pediatr Blood Cancer; 2006 Sep; 47(3):242-4. PubMed ID: 16421903
    [No Abstract]   [Full Text] [Related]  

  • 18. Modern diagnostics in acute leukemias.
    Haferlach T; Kern W; Schnittger S; Schoch C
    Crit Rev Oncol Hematol; 2005 Nov; 56(2):223-34. PubMed ID: 16213152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Childhood acute lymphoblastic leukemia in the age of genomics.
    Carroll WL; Bhojwani D; Min DJ; Moskowitz N; Raetz EA
    Pediatr Blood Cancer; 2006 May; 46(5):570-8. PubMed ID: 16365862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of acute myeloid leukemia and its impact on treatment.
    Frankfurt O; Licht JD; Tallman MS
    Curr Opin Oncol; 2007 Nov; 19(6):635-49. PubMed ID: 17906465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.